HIIT Versus MICT in COPD: Effects on Oxygenation, Pulmonary Function, and Strength
NCT ID: NCT07109687
Last Updated: 2025-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2025-10-01
2027-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to compare the effects of HIIT and Moderate-Intensity Continuous Training (MICT) on muscle oxygenation, pulmonary function, exercise capacity, and peripheral muscle strength in individuals with COPD. Participants will undergo an 8-week exercise program, twice weekly. HIIT will consist of 1-minute intervals at 90% and 30-40% of peak workload, while MICT will involve continuous cycling at 65% of peak workload. Outcomes will be assessed at baseline, week 4, and week 8. Data will be analyzed using SPSS. This study seeks to determine the more effective training modality to optimize COPD rehabilitation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Effects of Supramaximal High-Intensity Interval Training in People With COPD
NCT05874999
High-intensity Interval Training in Patients With COPD: a Fidelity and Tolerability Study
NCT05273684
Cardiopulmonary Adaptations to High-intensity Interval Training (HIIT) in COPD
NCT06551441
High Intensity Interval Training and Technologies in COPD
NCT05343949
Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease
NCT06068322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
standard aerobic exercise will apply in moderate intensity continuous training.
MICT
Moderate intensity continous exercise
interval exercise group
HIIT GROUP
Participants will perform a 31-minute protocol on a cycle ergometer consisting of 1-minute high-intensity intervals at 90% of peak workload (W peak) and low-intensity intervals at 30-40% of W peak, twice a week for 8 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HIIT GROUP
Participants will perform a 31-minute protocol on a cycle ergometer consisting of 1-minute high-intensity intervals at 90% of peak workload (W peak) and low-intensity intervals at 30-40% of W peak, twice a week for 8 weeks.
MICT
Moderate intensity continous exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GOLD stage 2, 3, or 4,
* Willing to participate in the study,
* Aged between 40 and 80 years,
* Clinically stable (no significant deterioration in the current medical condition, no recent initiation of a new treatment, and no complications requiring hospitalization).
Exclusion Criteria
* Any orthopedic, neurological, or cardiac conditions that may interfere with study participation or exercise,
* Presence of serious chronic diseases such as congestive heart failure, coronary artery disease, or chronic renal failure,
* Conditions that may cause physical limitations (e.g., limb amputation, significant musculoskeletal disorders, or postural abnormalities such as kyphosis or lordosis).
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Antalya Bilim University
OTHER
Hacettepe University
OTHER
Aynur Demirel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aynur Demirel
PT, PhD, Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fulsen Bozkus, MD., Prof.
Role: STUDY_DIRECTOR
Sağlık Bilimleri University Antalya Health Application and Research Center
Aynur Demirel, PT, PhD, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BSV-000021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.